Tempus AI, Inc. - TEM
About Gravity Analytica
Recent News
- 02.10.2026 - Tempus to Report Fourth Quarter and Full Year 2025 Financial Results on February 24
- 02.05.2026 - Accelerating a phase 1 oncology trial: The TIME Network’s impact on patient enrollment
- 02.05.2026 - Building the engine to scale data abstraction through AI
- 01.29.2026 - Ask a scientist: How to leverage novel datasets to answer complex research questions
- 01.28.2026 - OCT West Coast 2026
- 01.27.2026 - Beyond the blueprint: A scientific deep dive on RNA’s role in ADC strategy
- 01.27.2026 - Tempus Reveals Its AI-Driven IPS Test More Accurately Predicts Immunotherapy Benefit Compared to Conventional Biomarkers
- 01.21.2026 - Tempus Announces the Launch of Paige Predict
- 01.20.2026 - From image to insight: How Tempus is leveraging AI to advance biomarker screening at scale
- 01.20.2026 - Investigating LAG-3 expression as a biomarker in mRCC with multimodal data